image

ISSN: 1935-1232 (P)

ISSN: 1941-2010 (E)

image
image

Abstract

Clinical News

Author(s): Peter F. Buckley

Our field can be encouraged by several developments in the psychopharmacology of schizophrenia. We have previously described the initial clinical trials program of ITI-007. Results of two Phase 3 trials of ITI-007 have been reported as positive, with demonstrated antipsychotic efficacy and a favorable side effect profile (most prominently, mild sedation).